scispace - formally typeset
B

Bronwen Alice James Evans

Researcher at Cardiff University

Publications -  92
Citations -  4328

Bronwen Alice James Evans is an academic researcher from Cardiff University. The author has contributed to research in topics: Androgen & Osteoblast. The author has an hindex of 32, co-authored 92 publications receiving 4070 citations. Previous affiliations of Bronwen Alice James Evans include University of Cambridge & University of Wales.

Papers
More filters
Journal ArticleDOI

Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro

TL;DR: In conclusion, orthosilicic acid at physiological concentrations stimulates collagen type 1 synthesis in human osteoblast-like cells and enhances osteoblastic differentiation.
Journal ArticleDOI

Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids

TL;DR: In genital skin fibroblasts, genistein, biochanin A and equol were the most potent inhibitors of 5 alpha-reductase activity, each resulting in greater than 80% inhibition at a concentration of 100 microM.
Journal ArticleDOI

Phytoestrogen Concentrations in Serum from Japanese Men and Women over Forty Years of Age

TL;DR: The Japanese men and women had higher (P < 0.001) concentrations of circulating daidzein, genistein and equol than individuals from the UK and these results support previously published GC-MS results from studies with low numbers of samples.
Journal ArticleDOI

Bone mass acquisition in healthy children

TL;DR: This review considers the genetic, fetal, and environmental influences on bone mass acquisition in healthy children, and highlights important areas where paediatricians may have a role by counselling children and their families to adopt a healthy lifestyle which promotes bone health.
Journal ArticleDOI

Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome.

TL;DR: The results suggest that mutations affecting the ligand binding domain of the androgen receptor are the most frequent cause of AIS, although some cases of PAIS may be the result of other, as yet undefined, genetic lesions.